ArticleOncotarget2017

Efficacy of epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors (TKIs) in targeted therapy of lung squamous cell carcinoma patients with EGFR mutation: a pooled analysis.

Jingqi Zhuang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.